Results 81 to 90 of about 3,715,425 (177)

Factors associated with social functioning by relapse frequency in Japanese outpatients with schizophrenia: the Multicenter Treatment Survey and Assessments for Schizophrenia in Psychiatric Clinics (MUSASI). [PDF]

Psychol Med
Takekita Y, Katsumoto E, Adachi N, Kubota Y, Edagawa K, Azekawa T, Ueda H, Tamura T, Hongo S, Goto E, Hida H, Miki K, Fujii C, Watanabe K, Kato M, Yasui-Furukori N, Takeuchi H.   +16 more
europepmc   +1 more source

Prevalence and clinical characteristics of impulse control disorder in Southern Brazilian Parkinson's disease patients. [PDF]

Arq Neuropsiquiatr
Carvalho Neto EG, Soares NM, Pereira GM, Dalla Corte BM, Dutra ACL, Artigas NR, Almeida RMM, Krimberg JS, Monticelli BE, Schuh AFS, Rieder CRM.   +10 more
europepmc   +1 more source

An Underrecognized Problem: Missed and Delayed Carbidopa-Levodopa Administration in Emergency Department Patients With Parkinson's Disease. [PDF]

Acad Emerg Med
Elder NM, Lash EM, Tomkins-Tinch C.
europepmc   +1 more source

Extrapyramidal side effects with nonantipsychotic medications. [PDF]

Ment Health Clin
Koch J, Launio M, Williams AM.
europepmc   +1 more source

Four New Pairs of MetO-Containing Diketopiperazine Enantiomers: Isolation, Synthesis and Potential Anti-Parkinson's Disease Activity. [PDF]

Mar Drugs
Lei Y, Yang Z, Li D, Liao X, Hettiarachchi C, Zhao B, Xu S.   +6 more
europepmc   +1 more source

Post-marketing safety concerns with foscarbidopa/foslevodopa: A pharmacovigilance study with disproportionality analysis based on FAERS. [PDF]

Medicine (Baltimore)
Peng Y, Ding A, Zhang S, Kong F, Wu L, Sun W, Sun Z, Zheng X, Xi Y.   +8 more
europepmc   +1 more source

Acute Pharmacodynamic Effects of Oral Levodopa on Blood Pressure in Parkinson's Disease. [PDF]

Pharmacotherapy
Longardner K, Liu C, Momper J, Mahato K, Moonla C, Ghodsi H, Wang J, Litvan I.   +7 more
europepmc   +1 more source

Patient-reported outcomes and experiences with COMT inhibitors in the management of motor fluctuations in Parkinson's disease: a UK-based nested cross-sectional study. [PDF]

J Neurol
Noyce AJ, Akindele L, Shelton EL, Efthymiadou O, Periñan MT, Maio R, Harrison-Jones G, Ippolito M.   +7 more
europepmc   +1 more source

Identification, Screening and Mechanism Analysis of Anti-Parkinson's Disease Peptides from <i>Rapana venosa</i> Protein Hydrolysates. [PDF]

Mar Drugs
Wang Q, Shao S, Wang Y, Fan W, Wang Z, Liu X, Liu K, Zhang S.   +7 more
europepmc   +1 more source

Electrophysiological and biochemical evaluations of neuropathy risk in oral levodopa versus levodopa/carbidopa intestinal gel treatment. [PDF]

Arq Neuropsiquiatr
Erdem M, Selluncak B, Balal M, Fidanci H, Demirkiran M.   +4 more
europepmc   +1 more source